Aalok Shanghvi completed his graduation in Cellular and Molecular Biology from the University of Michigan, US.

Sun Pharmaceutical Industries has elevated Aalok Shanghvi, son of MD Dilip Shanghvi, as its new Chief Operating Officer.

Sun Pharma, India’s pharmaceutical giant, has elevated Aalok Shanghvi, the son of Dilip Shanghvi, chairman and managing ...

Sun Pharma appoints Aalok Shanghvi as COO, overseeing global operations and R&D, with expertise in emerging markets.

Sun Pharma has promoted Aalok Shanghvi to Chief Operating Officer. Previously a Whole-time Director, Shanghvi has been with the company since 2006. Known for his diverse role experience, he has ...

Results: Sun Pharmaceutical Industries on Friday said its consolidated net profit increased 15 per cent on-year to Rs 2,903 ...

The next generation has been entrusted with more responsibility at the family-run Sun Pharma, India’s largest drug maker, and ...

Sun Pharmaceutical Industries reported a 15 percent on-year increase in consolidated net profit, reaching Rs 2,903 crore for ...

Sun Pharma's net profit jumped 15% to Rs 2,903 crore in Q3 FY25, driven by strong sales across geographies. Revenue rose to ...